The Clinical Efficacy Application Of Percuteneous Transhepatic Cholangioscopy Lithotomy In The Treatment Of Hepatolithiasis

Objective:To discuss the feasibility of minimally invasive treatment and the clinical value of percutaneous transhepatic cholangioscopy lithotomy to hepatolithiasis, especially the advantage in the the complexity hepatolithiasis.Methods:Retrospective analyses the clinical data of 45 cases hepatolithiasis (19 male patients,26 female patients, aged from 20 to 84 years).45 patients were divided into experimental group, control group.The patients of experimental group received percutaneous transhepatic cholangioscopy lithotomy.The patients of control group received traditional operation, mainly in the common bile duct exploration, and the T tube drainage. When necessary, combined with hepatectomy, cholangiojejunostomy etc.To compare residual stone rate、after 1 year recurrence rate、postoperative complications etc.Results:Totally 43 patients included in the primary analysis. The experimental group had 2 patients due to puncture failure conversion to open operation. Two groups in residual stone rate, postoperative liver function recovery, after 1 year recurrence rate had no significant difference (P>0.05). In the intraoperative bleeding, operation time, postoperative complications, the recovery of gastrointestinal function after surgery, wound healing, pain score eat, the experimental group are better than the control group (P< 0.05).Conclusions:Percutaneous transhepatic choledochoscopic lithectomy can offer a minimally invasive alternative treatment to hepatolithiasis, and protect the liver function. This method has many advantages, such as less trauma, less complications, high stone extraction rate, low residual stone rate, slight pain score.